E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/16/2013 in the Prospect News Convertibles Daily.

New Issue: Vivus prices upsized $220 million seven-year convertibles to yield 4.5%, up 15%

By Rebecca Melvin

New York, May 16 - Vivus Inc. priced an upsized $220 million of seven-year convertible senior notes late Wednesday at par to yield 4.5% with an initial conversion premium of 15%, according to a news release.

The Rule 144A deal was initially talked at $200 million in size. Pricing came at the midpoint of 4.25% to 4.75% coupon talk and at the cheap end of 15% to 20% premium talk.

There is an over-allotment option for up to an additional $30 million of notes.

The deal was sold via bookrunner Deutsche Bank Securities Inc.

Proceeds will be used to commercialize products and develop product candidates and for general corporate purposes. About $30 million of the proceeds will be used to pay the cost of a capped call transaction with an affiliate of one of the initial purchasers of the notes.

The initial cap price is $20.00, boosting the effective premium from the issuer's perspective to 55%.

The notes are non-callable with no puts. They have net share settlement and contingent conversion if shares rise to 130% of the conversion price, and they have takeover protection.

Mountain View, Calif.-based Vivus is a pharmaceutical company focused on treatments for obesity and sexual dysfunction.

Issuer:Vivus Inc.
Issue:Convertible senior notes
Amount:$220 million, upsized from $200 million
Greenshoe:$30 million
Maturity:May 1, 2020
Bookrunner:Deutsche Bank Securities Inc.
Coupon:4.5%
Price:Par
Yield:4.5%
Conversion premium:15%
Conversion ratio:67.3038
Conversion price:$14.86
Calls:Non-callable
Puts:No puts
Net share settlement:Yes
Contingent conversion:Yes, at 130%
Capped call:Yes, initial cap price of $20.00, boosting premium from the issuer's perspective to 55%
Takeover protection:Yes
Price talk:4.25%-4.75%, up 15%-20%
Pricing date:May 15
Settlement date:May 21
Stock symbol:Nasdaq: VVUS
Stock reference price:$12.91 as of close May 15
Distribution:Rule 144A
Market capitalization:$1.3 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.